Jubilant Ingrevia acquires 100% equity stake in Remidex Pharma
This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4)
Jubilant Ingrevia has acquired 100% equity stake in Remidex Pharma (Remidex) pursuant to the Share Purchase Agreement entered into with Remidex.
This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4).
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
